Literature DB >> 27065321

SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.

X Shi1, Q Wang1, J Gu2, Z Xuan2, J I Wu1.   

Abstract

Recent large-scale genomic studies have classified medulloblastoma into four subtypes: Wnt, Shh, Group 3 and Group 4. Each is characterized by specific mutations and distinct epigenetic states. Previously, we showed that a chromatin regulator SMARCA4/Brg1 is required for Gli-mediated transcription activation in Sonic hedgehog (Shh) signaling. We report here that Brg1 controls a transcriptional program that specifically regulates Shh-type medulloblastoma growth. Using a mouse model of Shh-type medulloblastoma, we deleted Brg1 in precancerous progenitors and primary or transplanted tumors. Brg1 deletion significantly inhibited tumor formation and progression. Genome-wide expression analyses and binding experiments indicate that Brg1 specifically coordinates with key transcription factors including Gli1, Atoh1 and REST to regulate the expression of both oncogenes and tumor suppressors that are required for medulloblastoma identity and proliferation. Shh-type medulloblastoma displays distinct H3K27me3 properties. We demonstrate that Brg1 modulates activities of H3K27me3 modifiers to regulate the expression of medulloblastoma genes. Brg1-regulated pathways are conserved in human Shh-type medulloblastoma, and Brg1 is important for the growth of a human medulloblastoma cell line. Thus, Brg1 coordinates a genetic and epigenetic network that regulates the transcriptional program underlying the Shh-type medulloblastoma development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27065321     DOI: 10.1038/onc.2016.108

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  76 in total

1.  Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1.

Authors:  Gangqing Hu; Dustin E Schones; Kairong Cui; River Ybarra; Daniel Northrup; Qingsong Tang; Luca Gattinoni; Nicholas P Restifo; Suming Huang; Keji Zhao
Journal:  Genome Res       Date:  2011-07-27       Impact factor: 9.043

2.  Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.

Authors:  Joanna Triscott; Cathy Lee; Colleen Foster; Branavan Manoranjan; Mary Rose Pambid; Rachel Berns; Abbas Fotovati; Chitra Venugopal; Katrina O'Halloran; Aru Narendran; Cynthia Hawkins; Vijay Ramaswamy; Eric Bouffet; Michael D Taylor; Ash Singhal; Juliette Hukin; Rod Rassekh; Stephen Yip; Paul Northcott; Sheila K Singh; Christopher Dunham; Sandra E Dunn
Journal:  Cancer Res       Date:  2013-09-09       Impact factor: 12.701

Review 3.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

4.  Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice.

Authors:  Gabriel D Dakubo; Chantal J Mazerolle; Valerie A Wallace
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

Review 5.  Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health.

Authors:  Nikolay Popov; Jesús Gil
Journal:  Epigenetics       Date:  2010-11-01       Impact factor: 4.528

6.  The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes.

Authors:  C J Schoenherr; D J Anderson
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

7.  α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.

Authors:  Soma Sengupta; Shyamal Dilhan Weeraratne; Hongyu Sun; Jillian Phallen; Sundari K Rallapalli; Natalia Teider; Bela Kosaras; Vladimir Amani; Jessica Pierre-Francois; Yujie Tang; Brian Nguyen; Furong Yu; Simone Schubert; Brianna Balansay; Dimitris Mathios; Mirna Lechpammer; Tenley C Archer; Phuoc Tran; Richard J Reimer; James M Cook; Michael Lim; Frances E Jensen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2013-11-07       Impact factor: 17.088

8.  Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation.

Authors:  Yang Yu; Ying Chen; Bongwoo Kim; Haibo Wang; Chuntao Zhao; Xuelian He; Lei Liu; Wei Liu; Lai Man N Wu; Meng Mao; Jonah R Chan; Jiang Wu; Q Richard Lu
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

9.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

10.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

View more
  19 in total

Review 1.  Epigenetic regulation in medulloblastoma.

Authors:  Jiaqing Yi; Jiang Wu
Journal:  Mol Cell Neurosci       Date:  2017-12-18       Impact factor: 4.314

2.  PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma.

Authors:  Jiaqing Yi; BongWoo Kim; Xuanming Shi; Xiaoming Zhan; Q Richard Lu; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Res       Date:  2022-08-16       Impact factor: 13.312

Review 3.  Sonic Hedgehog Signaling in Cerebellar Development and Cancer.

Authors:  Wanchen Wang; Ryo Shiraishi; Daisuke Kawauchi
Journal:  Front Cell Dev Biol       Date:  2022-04-29

Review 4.  The current landscape of immunotherapy for pediatric brain tumors.

Authors:  Eugene I Hwang; Elias J Sayour; Catherine T Flores; Gerald Grant; Robert Wechsler-Reya; Lan B Hoang-Minh; Mark W Kieran; Joanne Salcido; Robert M Prins; John W Figg; Michael Platten; Kate M Candelario; Paul G Hale; Jason E Blatt; Lance S Governale; Hideho Okada; Duane A Mitchell; Ian F Pollack
Journal:  Nat Cancer       Date:  2022-01-20

Review 5.  SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy.

Authors:  Kristina Mardinian; Jacob J Adashek; Gregory P Botta; Shumei Kato; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2021-10-12       Impact factor: 6.009

6.  Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.

Authors:  Jiaqing Yi; Xuanming Shi; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Lett       Date:  2020-11-27       Impact factor: 8.679

7.  Comparative cell cycle transcriptomics reveals synchronization of developmental transcription factor networks in cancer cells.

Authors:  Johan Boström; Zuzana Sramkova; Alena Salašová; Helena Johard; Diana Mahdessian; Radek Fedr; Carolyn Marks; Jiřina Medalová; Karel Souček; Emma Lundberg; Sten Linnarsson; Vítězslav Bryja; Petra Sekyrova; Mikael Altun; Michael Andäng
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

Review 8.  The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.

Authors:  Qiong Wu; Jane B Lian; Janet L Stein; Gary S Stein; Jeffrey A Nickerson; Anthony N Imbalzano
Journal:  Epigenomics       Date:  2017-05-19       Impact factor: 4.778

9.  Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma.

Authors:  Tara H W Dobson; Rong-Hua Tao; Jyothishmathi Swaminathan; Shinji Maegawa; Shavali Shaik; Javiera Bravo-Alegria; Ajay Sharma; Bridget Kennis; Yanwen Yang; Keri Callegari; Amanda R Haltom; Pete Taylor; Mari Kogiso; Lin Qi; Soumen Khatua; Stewart Goldman; Rishi R Lulla; Jason Fangusaro; Tobey J MacDonald; Xiao-Nan Li; Cynthia Hawkins; Veena Rajaram; Vidya Gopalakrishnan
Journal:  Sci Signal       Date:  2019-01-22       Impact factor: 8.192

Review 10.  The Prowess of Andrographolide as a Natural Weapon in the War against Cancer.

Authors:  Ammad Ahmad Farooqi; Rukset Attar; Uteuliyev Yerzhan Sabitaliyevich; Nada Alaaeddine; Damião Pergentino de Sousa; Baojun Xu; William C Cho
Journal:  Cancers (Basel)       Date:  2020-08-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.